Biomedoz to close
Wednesday, 16 July, 2003
Online industry and share market watcher Biomedoz has called it a day. Last week, the site posted a note informing users that it would close "in the next couple of days".
Editor Bengt Norrman lamented the lack of interest realised by the site, from both industry and stakeholders. He described the last four years as "both fun and hard graft", but admitted that the company had failed to elicit a suitable partner to help fund the site and undertake further development.
"Philanthropy and love of the industry started Biomedoz," wrote Norrman. "Indifference and the hard cold facts of today's business environment brought it down. Perhaps there is one piece of hard-earned wisdom that we can share with you: philanthropy and business do not mix very well," he added.
Osteoarthritis study uncovers new genetic links, drug targets
The genome-wide association study (GWAS) uncovered over 900 genetic associations, more than 500...
How brain cells are affected by Tourette syndrome
US researchers have conducted a cell-by-cell analysis of brain tissue from individuals with...
Preventing neural graft rejection in Parkinson's patients
Researchers have engineered a way to fool the immune system into accepting neural grafts as part...
